Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features.

[1]  E. Krause,et al.  Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts. , 1996, The American journal of physiology.

[2]  B. Biondi,et al.  A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. , 1996, The New England journal of medicine.

[3]  K. Boheler,et al.  Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. , 1995, Circulation.

[4]  R. Walsh,et al.  Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca(2+)-ATPase protein levels. Effects on Ca2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. , 1995, Circulation research.

[5]  E. Lakatta,et al.  Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. , 1995, The American journal of physiology.

[6]  RenhuiYang,et al.  Growth Hormone Improves Cardiac Performance in Experimental Heart Failure , 1995 .

[7]  A. Moorman,et al.  Patterns of expression of sarcoplasmic reticulum Ca(2+)-ATPase and phospholamban mRNAs during rat heart development. , 1995, Circulation research.

[8]  R. Robinson,et al.  β2-Adrenergic Receptor Actions in Neonatal and Adult Rat Ventricular Myocytes , 1995 .

[9]  R. Robinson,et al.  Beta 2-adrenergic receptor actions in neonatal and adult rat ventricular myocytes. , 1995, Circulation research.

[10]  M. L. Kaplan,et al.  Alterations in gene expression in the rat heart after chronic pathological and physiological loads. , 1994, Journal of molecular and cellular cardiology.

[11]  R. Grange,et al.  Role of sarcoplasmic reticulum in loss of load-sensitive relaxation in pressure overload cardiac hypertrophy. , 1994, The American journal of physiology.

[12]  B. Lorell,et al.  Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. , 1993, Circulation research.

[13]  C. Maltin,et al.  Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. , 1993, Clinical science.

[14]  J. Widimský,et al.  Functional changes in the right and left ventricle during development of cardiac hypertrophy and after its regression. , 1992, Cardiovascular research.

[15]  K. Boheler,et al.  Gene expression in cardiac hypertrophy. , 1992, Trends in cardiovascular medicine.

[16]  J. S. Janicki,et al.  Cardioreparative Effects of Lisinopril in Rats With Genetic Hypertension and Left Ventricular Hypertrophy , 1991, Circulation.

[17]  K. Baker,et al.  Cardiac Hypertrophy: Mechanical, Neural, and Endocrine Dependence , 1991 .

[18]  C. Maltin,et al.  Effects of the cyclo‐oxygenase inhibitor, fenbufen, on clenbuterol‐induced hypertrophy of cardiac and skeletal muscle of rats , 1990, British journal of pharmacology.

[19]  Y. Lecarpentier,et al.  Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. , 1990, The Journal of clinical investigation.

[20]  G. Laurent,et al.  Application of high-pressure liquid chromatography to studies of collagen production by isolated cells in culture. , 1990, Analytical biochemistry.

[21]  A. Lompré,et al.  Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. , 1990, Circulation research.

[22]  K. Boheler,et al.  Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. , 1990, The Journal of clinical investigation.

[23]  R. Edwards,et al.  Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy. , 1989, Biochemical Journal.

[24]  I. Benjamin,et al.  Isoproterenol-Induced Myocardial Fibrosis in Relation to Myocyte Necrosis , 1989, Circulation research.

[25]  N. Alpert,et al.  Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J S Janicki,et al.  Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. , 1988, Cardiovascular research.

[27]  G. Radda,et al.  Hyperthyroidism results in increased glycolytic capacity in the rat heart , 1988 .

[28]  D. Chemla,et al.  Major alterations in relaxation during cardiac hypertrophy induced by aortic stenosis in guinea pig. , 1987, Circulation research.

[29]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[30]  M. Leon,et al.  Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. , 1987, Circulation.

[31]  C. Maltin,et al.  Propranolol apparently separates the physical and compositional characteristics of muscle growth induced by clenbuterol , 1987, Bioscience reports.

[32]  J. Scheuer,et al.  Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. , 1982, The Journal of clinical investigation.

[33]  P. Cockerill,et al.  A simplified method for quantitation of the relative amounts of type I and type III collagen in small tissue samples. , 1981, Analytical biochemistry.

[34]  H. Gavras,et al.  Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training. , 1979, The Journal of clinical investigation.

[35]  K. Rakušan,et al.  The growth of the muscular and collagenous parts of the rat heart in various forms of cardiomegaly , 1969, The Journal of physiology.